Literature DB >> 32816152

Overexpression of miR-27a predicts poor prognosis and promotes the progression in cholangiocarcinoma.

Yunxia Liu1, Xia Liu2, Yanhua Zhou3, Tingting Liu4, Jie Li4.   

Abstract

The function of microRNA-27a (miR-27a) expression in cholangiocarcinoma (CCA) remains largely unclear; therefore, this study aimed to investigate the clinical significance and functional role of miR-27a in CCA. This study included 117 paired CCA tissues and adjacent normal tissues from CCA patients who received surgical resection. Reverse transcription-quantitative polymerase chain reaction was used to measure the expression levels of miR-27a in CCA tissues and cell lines. A Kaplan-Meier curve and Cox regression analysis were used to determine overall prognostic performance. The effects of miR-27a on cell proliferation, migration, and invasion were measured by CCK-8 and Transwell assays. The expression levels of miR-27a in patients with CCA and cell lines were higher than those in adjacent normal tissues and normal cells, respectively. Additionally, miR-27a levels were found to be associated with lymph node metastasis and TNM stages. The overall survival time of CCA patients with high miR-27a expression was poorer than that of those with low miR-27a expression. Furthermore, miR-27a overexpression promoted CCA cell proliferation, migration, and invasion, whereas knockdown of miR-27a suppressed cell proliferation, migration, and invasion. Taken together, these results suggest the potential usefulness of miR-27a in the prognosis and progression of CCA.

Entities:  

Keywords:  Cholangiocarcinoma; Invasion; MicroRNA-27a; Migration; Prognosis; Proliferation

Year:  2020        PMID: 32816152     DOI: 10.1007/s10238-020-00655-y

Source DB:  PubMed          Journal:  Clin Exp Med        ISSN: 1591-8890            Impact factor:   3.984


  6 in total

1.  Reduced miR-300 expression predicts poor prognosis in patients with laryngeal squamous cell carcinoma.

Authors:  F-Y He; H-J Liu; Q Guo; J-L Sheng
Journal:  Eur Rev Med Pharmacol Sci       Date:  2017-02       Impact factor: 3.507

2.  MiR-27a-regulated FOXO1 promotes pancreatic ductal adenocarcinoma cell progression by enhancing Wnt/β-catenin signaling activity.

Authors:  Jing Ling; Xiao Dong; Lei Wang; Ying Xue; Xuebing Jia; Weifeng Song; Qi Li
Journal:  Am J Transl Res       Date:  2019-05-15       Impact factor: 4.060

3.  Expression profiles of oncomir miR-21 and tumor suppressor let-7a in the progression of opisthorchiasis-associated cholangiocarcinoma.

Authors:  N Namwat; P Chusorn; W Loilome; A Techasen; J Puetkasichonpasutha; C Pairojkul; N Khuntikeo; P Yongvanit
Journal:  Asian Pac J Cancer Prev       Date:  2012

4.  Long noncoding RNA LINC01296 promotes tumor growth and progression by sponging miR-5095 in human cholangiocarcinoma.

Authors:  Dawei Zhang; Haiyan Li; Juping Xie; Decan Jiang; Liangqi Cao; Xuewei Yang; Ping Xue; Xiaofeng Jiang
Journal:  Int J Oncol       Date:  2018-04-05       Impact factor: 5.650

5.  Tumor suppressor role of microRNA-545 in oral squamous cell carcinoma.

Authors:  Guangyi Yuan; Haoming Wu; Yu Du; Fanglin He
Journal:  Oncol Lett       Date:  2018-12-11       Impact factor: 2.967

6.  miR-27a-3p Functions as a Tumor Suppressor and Regulates Non-Small Cell Lung Cancer Cell Proliferation via Targeting HOXB8.

Authors:  Xiaohong Yan; Hui Yu; Yao Liu; Jie Hou; Qiao Yang; Yaning Zhao
Journal:  Technol Cancer Res Treat       Date:  2019-01-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.